EGFR EXON 20 MUTATION

Clinical trials for EGFR EXON 20 MUTATION explained in plain language.

Never miss a new study

Get alerted when new EGFR EXON 20 MUTATION trials appear

Sign up with your email to follow new studies for EGFR EXON 20 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Targeted pill tested to control Tough-to-Treat lung cancers

Disease control Terminated

This study tested an oral medication called poziotinib for people with advanced non-small cell lung cancer that had specific mutations in the EGFR or HER2 genes. The goal was to see if the drug could shrink tumors by blocking enzymes that help cancer cells grow. The trial involve…

Matched conditions: EGFR EXON 20 MUTATION

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

EGFR EXON 20 MUTATION

Get alerted when new EGFR EXON 20 MUTATION trials appear

Targeted pill tested to control Tough-to-Treat lung cancers